Real-world safety of ulinastatin: a post-marketing surveillance of 11,252 patients in China

BACKGROUND: The safety assessment of ulinastatin can guide clinical practice. The present study aimed to investigate the real-world safety of ulinastatin in China. METHODS: This multicenter study retrospectively analyzed the post-marketing surveillance data of consecutive patients treated with ulina...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jin, Li, Meijun, Li, Liren, Ma, Lin, Cao, Ailin, Wen, Aiping, Chen, Wenge, Li, Lingling, Liang, Yan, Deng, Jianxiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288682/
https://www.ncbi.nlm.nih.gov/pubmed/35842685
http://dx.doi.org/10.1186/s40360-022-00585-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288682/
https://www.ncbi.nlm.nih.gov/pubmed/35842685
http://dx.doi.org/10.1186/s40360-022-00585-3

Ejemplares similares